Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

NCT01449162 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Masitinib
DRUG: Placebo

Sponsor

AB Science